52
Participants
Start Date
June 11, 2025
Primary Completion Date
August 19, 2025
Study Completion Date
August 19, 2025
Omaveloxolone
Administered as specified in the treatment arm.
Trialmed formerly PPD, Austin Clinic, Austin
Lead Sponsor
Biogen
INDUSTRY